EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study
Not Applicable
Completed
- Conditions
- Peripheral Arterial Diseases
- Interventions
- Device: EverFlex™ stent with Entrust™ delivery system
- Registration Number
- NCT02066740
- Lead Sponsor
- Medtronic Endovascular
- Brief Summary
The purpose of this study is to collect acute confirmatory data to evaluate technical success and acute safety of the EverFlex™ self-expanding peripheral stent with Entrust™ delivery system.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
- Has stenotic, restenotic (from PTA or adjunct therapy, not including stents or stent grafts),
- or occluded lesion(s) located in the superficial femoral artery (SFA) and/or proximal popliteal artery (PPA) suitable for primary stenting.
Exclusion Criteria
- Has undergone previous implantation of stent(s) or stent graft(s) in the target vessel.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description EverFlex™ stent with Entrust™ delivery system EverFlex™ stent with Entrust™ delivery system -
- Primary Outcome Measures
Name Time Method Absence of Stent Elongation Intra operative Absence of stent elongation is achieved when the implanted stent length does not exceed the allowed stent length
Successful Stent Deployment Procedure Successful stent deployment to be assessed based on stent delivery, lesion coverage and accuracy of deployment.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Klinikum Weiden
🇩🇪Weiden, Germany